Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

General News

Summary

Dotmatics antibody workflow supports the breadth of antibody discovery by addressing these issues, giving organizations a cloud-based data management platform that is centralized and fully integrated with proven scientific applications and productivity tools that end-users trust. As scientists pursue critical antibody therapies to fight disease, Dotmatics is connecting them with their data in ways that accelerate innovation and help make the world a healthier, cleaner, safer place to live,” said Michael Swartz, senior vice president of enterprise product at Dotmatics. "We are at the forefront of a digital transformation in the scientific R&D industry with an emphasis on providing researchers end-to-end solutions with connected data and workflows. They should be able to use the tools they know and love, while still centralizing data in order to satisfy the needs of the organization.” The Dotmatics antibody workflow incorporates FAIR data practices and provides a uniquely broad and deep solution traversing early candidate selection through cycles of innovation to provide highly refined antibody candidates to progress into animal trial and translational medicine. For more information about Dotmatics and its new Biology Solution for Antibody Discovery visit the newly launched and rebranded Dotmatics.com or come along to booth 612 at Bio-IT World Conference & Expo in Boston, MA, May 3-5.

Classifications

industries
No industries detected
applications
Data Management

AskAI Classifications

Labels
Research and Development Software Scientific Software Bioinformatics

Linked Companies

Dotmatics
$100M to $250M